Down Syndrome Journal
Down
syndrome or subnormality, also called congenital anomaly, may be a inherited disorder caused by the presence of all or a part of a 3rd copy of
chromosome 21. it's usually related to physical growth delays, mild to moderate intellectual disability, and characteristic countenance. the typical IQ of a young adult with backwardness is 50, such as the power of an 8- or 9-year-old child, but this may vary widely.
The parents of the affected individual are usually genetically normal. The probability increases from but 0.1% in 20-year-old mothers to three in those old 45. the additional
chromosome is believed to occur unintentionally, with no known behavioral activity or
environmental factor that changes the probability.
mental retardation may be identified during pregnancy by prenatal
screening followed by diagnostic testing or after birth by direct observation and genetic testing. Since the introduction of screening, pregnancies with the diagnosis are often terminated. Regular
screening for
health problems common in trisomy is usually recommended throughout the person's life.
There is no cure for Down syndrome.
Education and proper care are shown to boost quality of life.Some children with mongolism are educated in typical school classes, while others require more specialized education. Some individuals with
mental retardation graduate from highschool, and some attend post-secondary education. In adulthood, about 20% within the us do paid add some capacity, with many requiring a sheltered work environment. Support in financial and legal matters is usually needed. expectancy is around 50 to 60 years within the developed world with proper
health care.
High Impact List of Articles
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Missing Data in Clinical Trials Forum
Terry L Katz
Conference Report: Clinical Investigation
-
Missing Data in Clinical Trials Forum
Terry L Katz
Conference Report: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
Relevant Topics in Clinical